Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H25N3.ClH |
| Molecular Weight | 331.883 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.C(CN1CCCCC1)N(CC2=NC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=MSVZUEGLXXVUJS-UHFFFAOYSA-N
InChI=1S/C19H25N3.ClH/c1-3-10-19(11-4-1)22(17-18-9-5-6-12-20-18)16-15-21-13-7-2-8-14-21;/h1,3-6,9-12H,2,7-8,13-17H2;1H
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugfuture.com/chemdata/Picoperine.html
LD50 orally in mice: 1900 mg/kg
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2142K55R4Y
Created by
admin on Mon Mar 31 21:20:58 GMT 2025 , Edited by admin on Mon Mar 31 21:20:58 GMT 2025
|
PRIMARY | |||
|
DTXSID90179436
Created by
admin on Mon Mar 31 21:20:58 GMT 2025 , Edited by admin on Mon Mar 31 21:20:58 GMT 2025
|
PRIMARY | |||
|
168198
Created by
admin on Mon Mar 31 21:20:58 GMT 2025 , Edited by admin on Mon Mar 31 21:20:58 GMT 2025
|
PRIMARY | |||
|
24699-40-9
Created by
admin on Mon Mar 31 21:20:58 GMT 2025 , Edited by admin on Mon Mar 31 21:20:58 GMT 2025
|
PRIMARY | |||
|
m8786
Created by
admin on Mon Mar 31 21:20:58 GMT 2025 , Edited by admin on Mon Mar 31 21:20:58 GMT 2025
|
PRIMARY | Merck Index |
SUBSTANCE RECORD